<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>Multimodal Analgesia in Spine Surgery</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <style>
        /* Prevent horizontal scroll */
        html, body {
            overflow-x: hidden;
            width: 100%;
        }

        /* Responsive container adjustments */
        .container {
            max-width: 100%;
            overflow-x: hidden;
        }

        /* Tab content */
        .tab-content {
            display: none;
            overflow-x: auto;
        }
        .tab-content.active {
            display: block;
        }

        /* Tab navigation - make scrollable on mobile */
        .tab-nav-container {
            overflow-x: auto;
            -webkit-overflow-scrolling: touch;
            scrollbar-width: thin;
        }
        .tab-nav-container::-webkit-scrollbar {
            height: 4px;
        }
        .tab-nav-container::-webkit-scrollbar-track {
            background: #f1f1f1;
        }
        .tab-nav-container::-webkit-scrollbar-thumb {
            background: #888;
            border-radius: 2px;
        }

        /* Expandable Outline Styles */
        .outline-container {
            max-width: 100%;
            margin: 0 auto;
            font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, 'Helvetica Neue', Arial, sans-serif;
            overflow-x: hidden;
        }

        .outline-list {
            list-style: none;
            padding: 0;
            margin: 0;
        }

        .outline-item {
            margin: 0;
            border-left: 2px solid transparent;
            transition: border-color 0.3s;
        }

        .outline-item:hover {
            border-left-color: #e2e8f0;
        }

        .outline-content {
            display: flex;
            align-items: center;
            padding: 8px 8px;
            cursor: pointer;
            border-radius: 6px;
            transition: all 0.2s;
            margin: 1px 0;
            word-wrap: break-word;
            overflow-wrap: break-word;
        }

        .outline-content:hover {
            background-color: #f8fafc;
        }

        .outline-toggle {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 16px;
            margin-right: 8px;
            color: #94a3b8;
            font-size: 14px;
            font-weight: 600;
            transition: all 0.2s;
            flex-shrink: 0;
        }

        .outline-toggle.expanded {
            transform: rotate(90deg);
            color: #475569;
        }

        .outline-text {
            flex: 1;
            line-height: 1.6;
            color: #334155;
            word-break: break-word;
            overflow-wrap: break-word;
        }

        .outline-children {
            list-style: none;
            padding: 0;
            margin: 0 0 0 20px;
            max-height: 0;
            overflow: hidden;
            opacity: 0;
            transition: all 0.3s ease-out;
        }

        .outline-children.expanded {
            max-height: none;
            opacity: 1;
            padding: 2px 0;
        }

        /* Level-specific styling - mobile adjusted */
        .level-0 > .outline-content {
            font-size: 1rem;
            font-weight: 600;
            color: #0f172a;
            margin: 10px 0 6px 0;
            padding: 8px;
        }

        .level-1 > .outline-content {
            font-size: 0.95rem;
            font-weight: 500;
            color: #1e293b;
            margin: 4px 0;
        }

        .level-2 > .outline-content {
            font-size: 0.9rem;
            font-weight: 400;
            color: #334155;
        }

        .level-3 > .outline-content {
            font-size: 0.85rem;
            font-weight: 400;
            color: #475569;
        }

        .level-4 > .outline-content {
            font-size: 0.825rem;
            font-weight: 400;
            color: #64748b;
        }

        /* No children - no toggle */
        .no-children > .outline-content {
            padding-left: 24px;
        }

        /* Control buttons */
        .outline-controls {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-bottom: 16px;
            padding: 10px;
            background-color: #fafafa;
            border-radius: 8px;
            border: 1px solid #e5e7eb;
        }

        .outline-controls button {
            padding: 6px 10px;
            border: 1px solid #d1d5db;
            background-color: white;
            color: #4b5563;
            border-radius: 4px;
            font-size: 0.813rem;
            font-weight: 400;
            cursor: pointer;
            transition: all 0.15s;
            white-space: nowrap;
            flex: 0 0 auto;
        }

        .outline-controls button:hover {
            background-color: #f9fafb;
            border-color: #9ca3af;
            color: #111827;
        }

        .outline-controls button:active {
            transform: scale(0.98);
        }

        /* Stats display */
        .outline-stats {
            width: 100%;
            margin-top: 8px;
            display: flex;
            align-items: center;
            font-size: 0.75rem;
            color: #6b7280;
        }

        .quiz-question {
            transition: all 0.3s;
        }
        .quiz-feedback {
            margin-top: 10px;
            padding: 10px;
            border-radius: 5px;
            display: none;
            word-wrap: break-word;
        }
        .correct-answer {
            background-color: #d4edda;
            border: 1px solid #c3e6cb;
            color: #155724;
        }
        .incorrect-answer {
            background-color: #f8d7da;
            border: 1px solid #f5c6cb;
            color: #721c24;
        }

        /* Mobile specific adjustments */
        @media (max-width: 768px) {
            .prose {
                font-size: 0.95rem;
            }

            .prose h2 {
                font-size: 1.5rem;
            }

            .prose h3 {
                font-size: 1.25rem;
            }

            .prose h4 {
                font-size: 1.1rem;
            }

            /* Adjust padding for mobile */
            .container {
                padding-left: 0.75rem;
                padding-right: 0.75rem;
            }

            /* Smaller buttons on mobile */
            button {
                font-size: 0.875rem;
            }

            /* Stack grid items on mobile */
            .grid {
                grid-template-columns: 1fr !important;
            }

            /* Adjust tab spacing */
            .tab-btn {
                padding: 0.5rem 0.75rem;
                font-size: 0.813rem;
            }

            /* Adjust outline indentation for mobile */
            .outline-children {
                margin-left: 16px;
            }

            .level-0 > .outline-content {
                font-size: 0.95rem;
            }

            .level-1 > .outline-content {
                font-size: 0.9rem;
            }

            .level-2 > .outline-content {
                font-size: 0.85rem;
            }

            .level-3 > .outline-content {
                font-size: 0.825rem;
            }

            .level-4 > .outline-content {
                font-size: 0.8rem;
            }
        }

        /* Ensure content boxes don't overflow */
        .bg-blue-50, .border-l-4 {
            word-wrap: break-word;
            overflow-wrap: break-word;
        }

        /* Make details/summary elements mobile-friendly */
        details {
            overflow: hidden;
        }

        details summary {
            overflow-wrap: break-word;
            word-break: break-word;
        }

        /* Ensure lists don't cause overflow */
        ul, ol {
            padding-left: 1.25rem;
        }

        @media (max-width: 640px) {
            ul, ol {
                padding-left: 1rem;
            }
        }
    </style>
</head>
<body class="bg-gray-50">
<div class="container mx-auto px-3 sm:px-4 py-4 sm:py-8 max-w-7xl">
    <header class="mb-6 sm:mb-8 text-center">
        <h1 class="text-2xl sm:text-3xl md:text-4xl font-bold text-blue-900 mb-2">Multimodal Analgesia in Spine Surgery</h1>
        <p class="text-sm sm:text-base md:text-lg text-gray-600 mb-2 px-2">A Comprehensive Study Guide and Interactive Learning Resource</p>
        <div class="text-xs sm:text-sm text-gray-500 border-t pt-3 mt-3 max-w-2xl mx-auto px-2">
            <p>Based on Grand Rounds Presentation (October 14, 2026) by <strong>Deepthi Penta, M.D.</strong></p>
            <p>Assistant Professor, General Anesthesiology</p>
            <p class="mt-2">Created by <strong>Brian Pitts, M.D., M.S., MEHP</strong></p>
        </div>
    </header>

    <!-- Tab Navigation -->
    <div class="border-b border-gray-200 mb-6 sm:mb-8">
        <div class="tab-nav-container">
            <nav class="-mb-px flex space-x-4 sm:space-x-8 min-w-max" aria-label="Tabs">
                <button onclick="switchTab('outline')" class="tab-btn text-blue-600 border-blue-600 whitespace-nowrap py-2 px-1 border-b-2 font-medium text-xs sm:text-sm" data-tab="outline">
                    Content Outline
                </button>
                <button onclick="switchTab('study')" class="tab-btn text-gray-500 border-transparent hover:text-gray-700 hover:border-gray-300 whitespace-nowrap py-2 px-1 border-b-2 font-medium text-xs sm:text-sm" data-tab="study">
                    Study Guide
                </button>
                <button onclick="switchTab('mindmap')" class="tab-btn text-gray-500 border-transparent hover:text-gray-700 hover:border-gray-300 whitespace-nowrap py-2 px-1 border-b-2 font-medium text-xs sm:text-sm" data-tab="mindmap">
                    Interactive Outline
                </button>
                <button onclick="switchTab('quiz')" class="tab-btn text-gray-500 border-transparent hover:text-gray-700 hover:border-gray-300 whitespace-nowrap py-2 px-1 border-b-2 font-medium text-xs sm:text-sm" data-tab="quiz">
                    Interactive Quiz
                </button>
            </nav>
        </div>
    </div>

    <!-- Tab Contents -->
    <div id="outline" class="tab-content active">
        <div class="bg-white rounded-lg shadow-lg p-4 sm:p-6 md:p-8 prose prose-sm sm:prose-base md:prose-lg max-w-none">
            <h2 class="text-2xl sm:text-3xl font-bold text-blue-900 mb-4 sm:mb-6">Overview</h2>
            <div class="bg-blue-50 p-4 sm:p-6 rounded-lg mb-6 sm:mb-8">
                <ul class="list-disc ml-4 sm:ml-5 space-y-2">
                    <li><strong>Definition:</strong> MMA = synergistic use of 2+ analgesic agents with different mechanisms</li>
                    <li><strong>Context:</strong> >1.2 million spine surgeries annually in US (5-75% high risk for severe postoperative pain)</li>
                    <li><strong>Problem:</strong> 20-70% of patients present with preoperative opioid use → poorer outcomes</li>
                    <li><strong>Major Finding:</strong> "Maximal" MMA (3+ agents) provides additional benefits over standard care</li>
                </ul>
            </div>

            <h2 class="text-xl sm:text-2xl font-bold text-blue-900 mt-6 sm:mt-8 mb-3 sm:mb-4">1. The Rationale for MMA in Spine Surgery</h2>

            <h3 class="text-lg sm:text-xl font-semibold mt-4 sm:mt-6 mb-2 sm:mb-3">A. The Challenge of Postoperative Pain</h3>
            <h4 class="font-semibold mb-2">Consequences of Inadequate Pain Management:</h4>
            <ul class="list-disc ml-4 sm:ml-5 space-y-1 mb-4">
                <li>Decreased mobility</li>
                <li>Increased complication rates (pneumonia, DVT)</li>
                <li>Negative impacts on social/emotional well-being</li>
            </ul>

            <h4 class="font-semibold mb-2">Benefits of Adequate Pain Control:</h4>
            <ul class="list-disc ml-4 sm:ml-5 space-y-1 mb-4">
                <li>Superior mobility and coordination</li>
                <li>Lower complication risk</li>
                <li>Quicker recovery</li>
                <li>Better surgical outcomes</li>
                <li>Improved patient satisfaction</li>
            </ul>

            <h3 class="text-lg sm:text-xl font-semibold mt-4 sm:mt-6 mb-2 sm:mb-3">B. Limitations of Traditional Opioid-Based Analgesia</h3>
            <ul class="list-disc ml-4 sm:ml-5 space-y-1 mb-4">
                <li>Delayed wound healing</li>
                <li>Urinary retention</li>
                <li>Nausea and vomiting</li>
                <li>Development of tolerance</li>
            </ul>

            <h3 class="text-lg sm:text-xl font-semibold mt-4 sm:mt-6 mb-2 sm:mb-3">C. Understanding Pain Pathways</h3>
            <div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
                <div>
                    <h4 class="font-semibold mb-2">Peripheral Pathway (Primary Hyperalgesia)</h4>
                    <ul class="list-disc ml-4 sm:ml-5 space-y-1 text-xs sm:text-sm">
                        <li>Surgical incision → cellular damage/inflammation</li>
                        <li>Activates prostaglandins (PGE-2, IL-6)</li>
                        <li>Overstimulation of peripheral nociceptors → acute pain</li>
                    </ul>
                </div>
                <div>
                    <h4 class="font-semibold mb-2">Central Pathway (Secondary Hyperalgesia)</h4>
                    <ul class="list-disc ml-4 sm:ml-5 space-y-1 text-xs sm:text-sm">
                        <li>NMDA receptor activation → prolonged CNS stimulation</li>
                        <li>Central sensitization → chronic pain</li>
                        <li>Mediators: COX, nitric oxide synthase (NOS)</li>
                    </ul>
                </div>
            </div>

            <h2 class="text-xl sm:text-2xl font-bold text-blue-900 mt-6 sm:mt-8 mb-3 sm:mb-4">2. Impact of Preoperative Opioid Use</h2>

            <h3 class="text-lg sm:text-xl font-semibold mt-4 sm:mt-6 mb-2 sm:mb-3">A. Prevalence and Negative Outcomes</h3>
            <p class="font-semibold mb-2">Prevalence: 20-70% use opioids preoperatively (nearly 20% opioid-dependent)</p>
            <h4 class="font-semibold mb-2">Associated Poor Outcomes:</h4>
            <ul class="list-disc ml-4 sm:ml-5 space-y-1 mb-4">
                <li>Higher inpatient opioid consumption</li>
                <li>Higher postoperative pain scores</li>
                <li>Greater post-surgical disability</li>
                <li>Increased hospital LOS</li>
                <li>Worsened functional/surgical outcomes</li>
                <li>Increased 90-day complications</li>
            </ul>

            <h3 class="text-lg sm:text-xl font-semibold mt-4 sm:mt-6 mb-2 sm:mb-3">B. Preoperative Opioid Tapering</h3>
            <ul class="list-disc ml-4 sm:ml-5 space-y-2 mb-4">
                <li><strong>Total Joint Arthroplasty Study:</strong> 50% reduction in morphine-equivalent dose → significantly improved functional outcomes</li>
                <li><strong>Spine Surgery Review:</strong> Patients on MEA >47.8 mg/day less likely to achieve minimum clinically important difference</li>
            </ul>

            <h3 class="text-lg sm:text-xl font-semibold mt-4 sm:mt-6 mb-2 sm:mb-3">C. Opioid-Induced Hyperalgesia (OIH)</h3>
            <ul class="list-disc ml-4 sm:ml-5 space-y-1 mb-4">
                <li><strong>Definition:</strong> Paradoxical increased pain sensitivity from chronic opioid exposure</li>
                <li><strong>Mechanism:</strong> NMDA receptor activation</li>
                <li><strong>Consequences:</strong> Loss of opioid efficacy, treatment challenges</li>
            </ul>

            <h2 class="text-xl sm:text-2xl font-bold text-blue-900 mt-6 sm:mt-8 mb-3 sm:mb-4">3. Analgesic Agents and Modalities</h2>

            <!-- Methadone -->
            <div class="border-l-4 border-blue-500 pl-3 sm:pl-4 mb-6">
                <h3 class="text-lg sm:text-xl font-semibold mb-2">Methadone</h3>
                <ul class="list-disc ml-4 sm:ml-5 space-y-1 text-sm sm:text-base">
                    <li>Potent mu-receptor agonist with long half-life (24-36 hours)</li>
                    <li>NMDA receptor antagonist + serotonin/norepinephrine reuptake inhibitor</li>
                    <li>Dosing: 0.15-0.2 mg/kg ideal body weight (max 20 mg)</li>
                    <li>Clinical evidence shows decreased pain/opioids for 72 hours vs fentanyl</li>
                </ul>
            </div>

            <!-- NSAIDs -->
            <div class="border-l-4 border-green-500 pl-3 sm:pl-4 mb-6">
                <h3 class="text-lg sm:text-xl font-semibold mb-2">NSAIDs</h3>
                <ul class="list-disc ml-4 sm:ml-5 space-y-1 text-sm sm:text-base">
                    <li>COX enzyme inhibition → blocked prostaglandin production</li>
                    <li>Concern: Risk of nonunion is dose/duration-dependent</li>
                    <li>High-dose ketorolac (>120 mg/day) increases risk</li>
                    <li>Parecoxib → 39% reduction in morphine use</li>
                </ul>
            </div>

            <!-- Gabapentinoids -->
            <div class="border-l-4 border-purple-500 pl-3 sm:pl-4 mb-6">
                <h3 class="text-lg sm:text-xl font-semibold mb-2">Gabapentinoids</h3>
                <ul class="list-disc ml-4 sm:ml-5 space-y-1 text-sm sm:text-base">
                    <li>Inhibit alpha 2-delta subunit of voltage-gated calcium channels</li>
                    <li>Reduce excitatory neurotransmitter release</li>
                    <li>Caution: 50% increased odds of naloxone requirement with opioids</li>
                </ul>
            </div>

            <!-- Ketamine -->
            <div class="border-l-4 border-red-500 pl-3 sm:pl-4 mb-6">
                <h3 class="text-lg sm:text-xl font-semibold mb-2">Ketamine</h3>
                <ul class="list-disc ml-4 sm:ml-5 space-y-1 text-sm sm:text-base">
                    <li>CNS NMDA receptor antagonist</li>
                    <li>ASRA recommended for opioid-tolerant patients</li>
                    <li>Dosing: 0.35 mg/kg bolus + 0.1-0.5 mg/kg/hr infusion</li>
                    <li>Meta-analysis: Lower pain and opioid use up to 48 hours</li>
                </ul>
            </div>

            <h2 class="text-xl sm:text-2xl font-bold text-blue-900 mt-6 sm:mt-8 mb-3 sm:mb-4">4. "Maximal" MMA Efficacy</h2>
            <h3 class="font-semibold mb-3">Meta-Analysis Key Findings (12 studies)</h3>
            <p class="font-semibold mb-2">≥3 agents vs ≤2 agents:</p>
            <ul class="list-disc ml-4 sm:ml-5 space-y-1 mb-6">
                <li>Significantly decreased pain scores at 12, 24, and 48 hours</li>
                <li>Decreased opioid consumption at 24 and 48 hours</li>
                <li>Significantly shorter hospital LOS</li>
                <li>No significant difference in PONV or respiratory events</li>
            </ul>

            <h2 class="text-xl sm:text-2xl font-bold text-blue-900 mt-6 sm:mt-8 mb-3 sm:mb-4">5. Regional Anesthesia: ESP Block</h2>
            <ul class="list-disc ml-4 sm:ml-5 space-y-1 mb-6">
                <li>Paraspinal fascial plane block between erector spinae and transverse process</li>
                <li>Blocks dorsal rami, potential paravertebral spread</li>
                <li>8/9 studies: significant opioid reduction (up to 48 hours)</li>
                <li>9/9 studies: significant pain score decrease</li>
            </ul>

            <h2 class="text-xl sm:text-2xl font-bold text-blue-900 mt-6 sm:mt-8 mb-3 sm:mb-4">6. Conclusion</h2>
            <ul class="list-disc ml-4 sm:ml-5 space-y-2">
                <li>MMA should be standard of care for spine surgery pain management</li>
                <li>"Maximal" approach (3+ agents) yields superior outcomes</li>
                <li>Future research needed on optimal combinations and personalized approaches</li>
            </ul>
        </div>
    </div>

    <div id="study" class="tab-content">
        <div class="bg-white rounded-lg shadow-lg p-4 sm:p-6 md:p-8">
            <h2 class="text-2xl sm:text-3xl font-bold text-blue-900 mb-4 sm:mb-6">Study Guide</h2>

            <!-- Short Answer Questions -->
            <div class="mb-6 sm:mb-8">
                <h3 class="text-xl sm:text-2xl font-semibold text-gray-800 mb-3 sm:mb-4">Short-Answer Questions</h3>
                <div class="space-y-3 sm:space-y-4">
                    <details class="border p-3 sm:p-4 rounded">
                        <summary class="font-semibold cursor-pointer text-sm sm:text-base">1. What is the definition of multimodal analgesia (MMA), and what is its primary goal?</summary>
                        <p class="mt-3 text-gray-700 p-2 sm:p-3 text-sm sm:text-base">Multimodal analgesia is defined as the simultaneous use of two or more agents that act synergistically through different mechanisms to provide pain control. Its goal is to improve pain control by targeting different pathways, thereby reducing the amount of opioids needed and their associated adverse side effects.</p>
                    </details>

                    <details class="border p-3 sm:p-4 rounded">
                        <summary class="font-semibold cursor-pointer text-sm sm:text-base">2. Describe the negative effects of preoperative opioid use on outcomes for spine surgery patients.</summary>
                        <p class="mt-3 text-gray-700 p-2 sm:p-3 text-sm sm:text-base">Preoperative opioid use is associated with several negative outcomes, including higher inpatient opioid consumption, higher pain scores, and greater post-operative disability. It can also lead to increased hospital length of stay, worsened functional/surgical outcomes, and an increased likelihood of 90-day complications.</p>
                    </details>

                    <details class="border p-3 sm:p-4 rounded">
                        <summary class="font-semibold cursor-pointer text-sm sm:text-base">3. Explain the phenomenon of Opioid-Induced Hyperalgesia (OIH) and identify the receptor that may play a central role in its development.</summary>
                        <p class="mt-3 text-gray-700 p-2 sm:p-3 text-sm sm:text-base">Opioid-Induced Hyperalgesia is a paradoxical adverse response defined as an increased sensitivity to painful stimuli resulting from chronic opioid exposure. NMDA receptor activation is thought to play a central role in this phenomenon, which can lead to a loss of opioid efficacy.</p>
                    </details>

                    <details class="border p-3 sm:p-4 rounded">
                        <summary class="font-semibold cursor-pointer text-sm sm:text-base">4. Methadone has multi-receptor pharmacology. Besides being a potent mu-receptor agonist, what are its other mechanisms of action?</summary>
                        <p class="mt-3 text-gray-700 p-2 sm:p-3 text-sm sm:text-base">In addition to being an opioid mu-receptor agonist, methadone is also a potent NMDA receptor antagonist and a serotonin/norepinephrine reuptake inhibitor. These properties may help counteract opioid-induced hyperalgesia.</p>
                    </details>

                    <details class="border p-3 sm:p-4 rounded">
                        <summary class="font-semibold cursor-pointer text-sm sm:text-base">5. What are the primary concerns associated with the use of NSAIDs in spinal fusion surgeries, and how might these concerns be mitigated?</summary>
                        <p class="mt-3 text-gray-700 p-2 sm:p-3 text-sm sm:text-base">The primary concerns are pseudoarthrosis, nonunion, and post-operative bleeding. A meta-analysis suggests the risk of nonunion is associated with high-dose ketorolac (>120 mg/day), but not with short-term use of NSAIDs at normal doses, and animal studies indicate the risk may be mitigated with selective COX-2 inhibitors like celecoxib.</p>
                    </details>
                </div>
            </div>

            <!-- Essay Questions -->
            <div class="mb-6 sm:mb-8">
                <h3 class="text-xl sm:text-2xl font-semibold text-gray-800 mb-3 sm:mb-4">Essay Questions</h3>
                <div class="space-y-2 sm:space-y-3">
                    <p class="font-medium text-sm sm:text-base">1. Construct a comprehensive rationale for implementing MMA in spine surgery. Your answer should detail the risks of traditional opioid-only management, the benefits of adequate pain control, and the synergistic philosophy behind targeting multiple pain pathways.</p>
                    <p class="font-medium text-sm sm:text-base">2. Compare and contrast the mechanisms of action, benefits, and potential risks of three different NMDA receptor antagonists discussed in the source material: ketamine, methadone, and magnesium.</p>
                    <p class="font-medium text-sm sm:text-base">3. Using the provided diagrams of pain pathways, explain the processes of peripheral (primary hyperalgesia) and central sensitization (secondary hyperalgesia). Then, identify at least four different classes of analgesic agents and describe where each one acts within these pathways.</p>
                    <p class="font-medium text-sm sm:text-base">4. Several studies presented evidence on the efficacy of NSAIDs and gabapentinoids for post-operative pain management in spine surgery. Synthesize the findings from the relevant tables and text to evaluate the strength of the evidence for each drug class.</p>
                    <p class="font-medium text-sm sm:text-base">5. Based on the source material, develop an argument for the preoperative tapering of opioids for chronic users scheduled for spine surgery.</p>
                </div>
            </div>

            <!-- Glossary -->
            <div>
                <h3 class="text-xl sm:text-2xl font-semibold text-gray-800 mb-3 sm:mb-4">Glossary</h3>
                <div class="grid grid-cols-1 md:grid-cols-2 gap-2 sm:gap-4">
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">Acetaminophen</h4>
                        <p class="text-xs sm:text-sm mt-1">A central inhibitor of COX enzymes (COX-1, -2, -3) and prostaglandin synthesis. Front-line analgesic for mild to moderate pain.</p>
                    </div>
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">Central Sensitization</h4>
                        <p class="text-xs sm:text-sm mt-1">Prolonged CNS stimulation via NMDA receptor activation, leading to secondary hyperalgesia and chronic pain.</p>
                    </div>
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">COX Enzymes</h4>
                        <p class="text-xs sm:text-sm mt-1">Cyclooxygenase enzymes that mediate prostaglandin synthesis. COX-1 affects GI mucosa/platelets; COX-2 is specific to inflammatory tissues.</p>
                    </div>
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">ESP Block</h4>
                        <p class="text-xs sm:text-sm mt-1">Erector Spinae Plane Block - paraspinal fascial plane block between erector spinae muscle and thoracic transverse process.</p>
                    </div>
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">Gabapentinoids</h4>
                        <p class="text-xs sm:text-sm mt-1">Drugs (gabapentin, pregabalin) that inhibit alpha 2-delta subunit of voltage-gated calcium channels on presynaptic axons.</p>
                    </div>
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">Ketamine</h4>
                        <p class="text-xs sm:text-sm mt-1">NMDA receptor antagonist that decreases nociceptive signal sensitization. Also decreases serotonin/norepinephrine reuptake.</p>
                    </div>
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">Methadone</h4>
                        <p class="text-xs sm:text-sm mt-1">Potent opioid mu-receptor agonist with long half-life, NMDA antagonist, and serotonin/norepinephrine reuptake inhibitor.</p>
                    </div>
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">MMA</h4>
                        <p class="text-xs sm:text-sm mt-1">Multimodal Analgesia - simultaneous use of 2+ analgesic agents with different mechanisms for synergistic pain control.</p>
                    </div>
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">NMDA Receptor</h4>
                        <p class="text-xs sm:text-sm mt-1">N-methyl-D-aspartate receptor. Its activation causes central sensitization and is implicated in OIH.</p>
                    </div>
                    <div class="p-3 sm:p-4 border-b">
                        <h4 class="font-bold text-blue-700 text-sm sm:text-base">OIH</h4>
                        <p class="text-xs sm:text-sm mt-1">Opioid-Induced Hyperalgesia - paradoxical increased pain sensitivity from chronic opioid exposure.</p>
                    </div>
                </div>
            </div>
        </div>
    </div>

    <div id="mindmap" class="tab-content">
        <div class="bg-white rounded-lg shadow-lg p-4 sm:p-6 md:p-8">
            <h2 class="text-2xl sm:text-3xl font-bold text-gray-900 mb-2">Interactive Outline</h2>
            <p class="text-gray-500 mb-4 sm:mb-6 text-xs sm:text-sm">Navigate through the content hierarchy. Click arrows to expand or collapse sections.</p>
            <div id="mindMapContainer"></div>
        </div>
    </div>

    <div id="quiz" class="tab-content">
        <div class="bg-white rounded-lg shadow-lg p-4 sm:p-6 md:p-8">
            <h2 class="text-2xl sm:text-3xl font-bold text-blue-900 mb-4 sm:mb-6">Interactive Quiz</h2>
            <div id="quizContainer"></div>
            <div class="mt-6 sm:mt-8">
                <button onclick="checkAnswers()" class="bg-blue-600 text-white px-4 sm:px-6 py-2 sm:py-3 rounded hover:bg-blue-700 transition text-sm sm:text-base">
                    Check Answers
                </button>
                <button onclick="resetQuiz()" class="ml-2 sm:ml-4 bg-gray-600 text-white px-4 sm:px-6 py-2 sm:py-3 rounded hover:bg-gray-700 transition text-sm sm:text-base">
                    Reset Quiz
                </button>
                <div id="scoreDisplay" class="mt-4 text-lg sm:text-xl font-semibold hidden"></div>
            </div>
        </div>
    </div>
</div>

<script>
    // Mind Map Data Structure
    const mindMapData = {
        text: "Multimodal Analgesia in Major Surgery",
        level: 0,
        children: [
            {
                text: "Definition and Goals of MMA",
                level: 1,
                children: [
                    {
                        text: "Core Principles",
                        level: 2,
                        children: [
                            { text: "Simultaneous use of ≥2 agents", level: 3 },
                            { text: "Agents with differing mechanisms (non-redundant)", level: 3 },
                            { text: "Targets different pain pathways", level: 3 },
                            { text: "Reduces opioid use and adverse effects", level: 3 }
                        ]
                    },
                    {
                        text: "Benefits and Goals",
                        level: 2,
                        children: [
                            { text: "Improves multidimensional recovery", level: 3 },
                            { text: "Lowers risk of complications", level: 3 },
                            { text: "Quicker recovery", level: 3 },
                            { text: "Improved patient satisfaction", level: 3 }
                        ]
                    },
                    {
                        text: "Global Analgesic Pain Control",
                        level: 2,
                        children: [
                            { text: "Improves mobility and function", level: 3 },
                            { text: "Lowers risk of complications", level: 3 },
                            { text: "Quicker recovery", level: 3 },
                            { text: "Improved patient satisfaction", level: 3 }
                        ]
                    }
                ]
            },
            {
                text: "Rationale for MMA in Surgery",
                level: 1,
                children: [
                    {
                        text: "Key Statistics and Risks",
                        level: 2,
                        children: [
                            { text: ">3 million major operations in US annually", level: 3 },
                            {
                                text: "High Risk Postoperative Pain (>75%)",
                                level: 3,
                                children: [
                                    { text: "Delayed functional recovery", level: 4 },
                                    { text: "Increased morbidity", level: 4 },
                                    { text: "Increased complications (pneumonia, DVT)", level: 4 },
                                    { text: "Impaired neuroendocrine health", level: 4 }
                                ]
                            }
                        ]
                    }
                ]
            },
            {
                text: "Pain Pathways",
                level: 1,
                children: [
                    {
                        text: "Nociceptive Pathways",
                        level: 2,
                        children: [
                            { text: "Transduction, Transmission, Perception, Modulation", level: 3 },
                            { text: "Triggers: tissue damage, cellular change", level: 3 },
                            { text: "Activation of local prostaglandins (PGs)", level: 3 },
                            { text: "Decreased threshold of nociceptors", level: 3 },
                            { text: "Release: TNF-α, IL-1β, IL-6", level: 3 }
                        ]
                    },
                    {
                        text: "Physiologic/Pathophysiologic Pathways",
                        level: 2,
                        children: [
                            { text: "Peripheral inflammation", level: 3 },
                            { text: "Central sensitization", level: 3 },
                            { text: "Prolonged neuronal excitation", level: 3 },
                            { text: "Chronic postsurgical pain", level: 3 },
                            { text: "Mediators: CGRP, NMDA, NK1 → hyperalgesia", level: 3 }
                        ]
                    }
                ]
            },
            {
                text: "Opioids and Perioperative Use",
                level: 1,
                children: [
                    {
                        text: "Opioid Use Pre-Surgery",
                        level: 2,
                        children: [
                            { text: "Common: 25-30% of patients", level: 3 },
                            { text: "Nearly 30% opioid dependence", level: 3 },
                            { text: "Associated with negative effects", level: 3 }
                        ]
                    },
                    {
                        text: "Opioid Taper Prior to Surgery",
                        level: 2,
                        children: [
                            { text: "May improve recovery, minimize pain", level: 3 },
                            { text: "Major surgery candidates: 7-30 days for MMA focus", level: 3 },
                            { text: "Increased sensitivity to opioid stimuli", level: 3 }
                        ]
                    },
                    {
                        text: "Opioid-Induced Hyperalgesia (OIH)",
                        level: 2,
                        children: [
                            { text: "Paradoxical increase in pain response", level: 3 },
                            { text: "NMDA receptor activation", level: 3 },
                            { text: "Loss of spinal reflex inhibition", level: 3 },
                            { text: "Associated with prolonged mechanical and thermal sensitivity", level: 3 }
                        ]
                    }
                ]
            },
            {
                text: "Agents Used in MMA (Systemic)",
                level: 1,
                children: [
                    {
                        text: "Acetaminophen",
                        level: 2,
                        children: [
                            { text: "Central inhibitor of COX pathway", level: 3 },
                            { text: "Reduces pain and opioid consumption", level: 3 },
                            { text: "Good safety profile, minimal adverse effects", level: 3 },
                            { text: "Combination with NSAIDs → synergistic response", level: 3 }
                        ]
                    },
                    {
                        text: "NSAIDs",
                        level: 2,
                        children: [
                            { text: "Blocks PG production", level: 3 },
                            { text: "COX-1 effects: platelet inhibition", level: 3 },
                            { text: "COX-2 effects: anti-inflammatory", level: 3 },
                            { text: "Common: Ibuprofen, Ketorolac; primary bleeding risk", level: 3 },
                            { text: "High-dose ketorolac (>120 mg/day) increases renal risk", level: 3 }
                        ]
                    },
                    {
                        text: "Gabapentinoids (Gabapentin, Pregabalin)",
                        level: 2,
                        children: [
                            { text: "Useful for neuropathic pain", level: 3 },
                            { text: "Blocks alpha-2-delta subunit of voltage-gated Ca²⁺ channels", level: 3 },
                            { text: "Reduces excitatory release", level: 3 },
                            { text: "Side effects: sedation, dizziness", level: 3 },
                            { text: "Increases sedation synergistically when combined with opioids", level: 3 }
                        ]
                    },
                    {
                        text: "Ketamine",
                        level: 2,
                        children: [
                            { text: "Recommended by ASA in select patient populations", level: 3 },
                            { text: "NMDA receptor antagonist (analgesic properties)", level: 3 },
                            { text: "Opioid-sparing, anti-hyperalgesic", level: 3 },
                            { text: "Useful for acute and chronic pain", level: 3 },
                            { text: "Dose: Bolus 0.1-0.5 mg/kg, Infusion 0.1-0.3 mg/kg/hr", level: 3 },
                            { text: "Caution: Increased salivation, hallucinations at high doses", level: 3 }
                        ]
                    },
                    {
                        text: "Magnesium",
                        level: 2,
                        children: [
                            { text: "NMDA receptor antagonist, promotes calcium homeostasis", level: 3 },
                            { text: "Modulates CNS excitatory signaling pathways", level: 3 },
                            { text: "Reduced pain and opioid requirements", level: 3 },
                            { text: "Ideal dosing: Loading 30-50 mg/kg, Infusion 6-20 mg/kg/hr", level: 3 },
                            { text: "Caution: Prolonged neuromuscular blockade", level: 3 }
                        ]
                    },
                    {
                        text: "Dexmedetomidine (Precedex)",
                        level: 2,
                        children: [
                            { text: "Alpha-2 agonist, commonly used in major MMA protocols", level: 3 },
                            { text: "Hemodynamic stability, sympatholytic", level: 3 },
                            { text: "Perioperative opioid-sparing effect", level: 3 },
                            { text: "Reduced PONV and sedation in PACU", level: 3 }
                        ]
                    }
                ]
            },
            {
                text: "Regional Techniques for Major Surgery",
                level: 1,
                children: [
                    {
                        text: "Nerve Blocks",
                        level: 2,
                        children: [
                            { text: "Recommended by ERAS protocols", level: 3 },
                            { text: "Thoracic Epidural, PECS (TAP) Block", level: 3 },
                            { text: "Quadratus Lumborum Block", level: 3 },
                            { text: "Spine/Trunk Plane Blocks (ESP)", level: 3 },
                            { text: "Benefits: Decreased pain at 24h post-op, decreased opioid use, reduced PONV", level: 3 }
                        ]
                    },
                    {
                        text: "Perioperative Outcomes",
                        level: 2,
                        children: [
                            { text: "Periop regional analgesia decreased LOS 0.4-0.8 days", level: 3 },
                            { text: "Hospital LOS significantly shorter", level: 3 },
                            { text: "Reduced PONV and respiratory complications", level: 3 },
                            { text: "Multimodal block combinations enhance recovery", level: 3 }
                        ]
                    }
                ]
            }
        ]
    };

    // Quiz Questions
    const quizQuestions = [
        {
            question: "What is the definition of multimodal analgesia (MMA)?",
            options: [
                "Using only opioids for pain control",
                "Simultaneous use of two or more agents acting through different mechanisms",
                "Sequential use of different pain medications",
                "Using the highest dose of a single medication"
            ],
            correct: 1,
            explanation: "MMA is defined as the simultaneous use of two or more agents that act synergistically through different mechanisms to provide pain control."
        },
        {
            question: "What percentage of spine surgery patients present with preoperative opioid use?",
            options: [
                "5-10%",
                "10-20%",
                "20-70%",
                "80-90%"
            ],
            correct: 2,
            explanation: "20-70% of patients use opioids preoperatively, with nearly 20% being opioid-dependent."
        },
        {
            question: "Which receptor plays a central role in Opioid-Induced Hyperalgesia?",
            options: [
                "GABA receptor",
                "NMDA receptor",
                "Dopamine receptor",
                "Serotonin receptor"
            ],
            correct: 1,
            explanation: "NMDA receptor activation is thought to play a central role in OIH."
        },
        {
            question: "Besides being a mu-receptor agonist, methadone also functions as:",
            options: [
                "COX inhibitor only",
                "NMDA antagonist and serotonin/norepinephrine reuptake inhibitor",
                "Calcium channel blocker",
                "Beta blocker"
            ],
            correct: 1,
            explanation: "Methadone is also a potent NMDA receptor antagonist and a serotonin/norepinephrine reuptake inhibitor."
        },
        {
            question: "What is the maximum safe daily dose of ketorolac to avoid increased nonunion risk?",
            options: [
                "60 mg/day",
                "90 mg/day",
                "120 mg/day",
                "150 mg/day"
            ],
            correct: 2,
            explanation: "High-dose ketorolac (>120 mg/day) increases the risk of nonunion."
        },
        {
            question: "Gabapentinoids work by inhibiting which structure?",
            options: [
                "NMDA receptors",
                "COX enzymes",
                "Alpha 2-delta subunit of voltage-gated calcium channels",
                "Sodium channels"
            ],
            correct: 2,
            explanation: "Gabapentinoids inhibit the alpha 2-delta subunit of voltage-gated calcium channels on presynaptic axons."
        },
        {
            question: "According to the meta-analysis, 'maximal' MMA is defined as using how many agents?",
            options: [
                "1 agent",
                "2 agents",
                "3 or more agents",
                "5 or more agents"
            ],
            correct: 2,
            explanation: "The meta-analysis defined 'maximal' MMA as using three or more analgesic agents."
        },
        {
            question: "What is the recommended ketamine bolus dose for perioperative use?",
            options: [
                "0.01-0.05 mg/kg",
                "0.1-0.5 mg/kg",
                "1-2 mg/kg",
                "5-10 mg/kg"
            ],
            correct: 1,
            explanation: "The recommended dose is a bolus of 0.1-0.5 mg/kg (often 0.35 mg/kg) followed by an infusion."
        },
        {
            question: "The ESP block is placed between which structures?",
            options: [
                "Skin and muscle",
                "Erector spinae muscle and thoracic transverse process",
                "Between vertebrae",
                "In the epidural space"
            ],
            correct: 1,
            explanation: "The ESP block is a paraspinal fascial plane block placed between the erector spinae muscle and the thoracic transverse process."
        },
        {
            question: "What was a key finding regarding hospital length of stay with maximal MMA?",
            options: [
                "No difference",
                "Increased length of stay",
                "Significantly shorter length of stay",
                "Variable results"
            ],
            correct: 2,
            explanation: "The intervention group using 3+ agents had a significantly shorter hospital length of stay."
        }
    ];

    // Tab Switching
    function switchTab(tabName) {
        // Hide all tabs
        document.querySelectorAll('.tab-content').forEach(tab => {
            tab.classList.remove('active');
        });

        // Remove active styling from all buttons
        document.querySelectorAll('.tab-btn').forEach(btn => {
            btn.classList.remove('text-blue-600', 'border-blue-600');
            btn.classList.add('text-gray-500', 'border-transparent');
        });

        // Show selected tab
        document.getElementById(tabName).classList.add('active');

        // Add active styling to selected button
        const activeBtn = document.querySelector(`[data-tab="${tabName}"]`);
        activeBtn.classList.remove('text-gray-500', 'border-transparent');
        activeBtn.classList.add('text-blue-600', 'border-blue-600');

        // Initialize mind map if switching to that tab
        if (tabName === 'mindmap' && !document.getElementById('mindMapContainer').hasChildNodes()) {
            initializeMindMap();
        }

        // Initialize quiz if switching to that tab
        if (tabName === 'quiz' && !document.getElementById('quizContainer').hasChildNodes()) {
            initializeQuiz();
        }
    }

    // Mind Map Functions (Expandable Outline)
    let totalNodes = 0;
    let expandedNodes = 0;

    function createOutlineNode(data, isExpanded = false) {
        totalNodes++;
        if (isExpanded) expandedNodes++;

        const li = document.createElement('li');
        li.className = `outline-item level-${data.level}`;

        // Create content container
        const contentDiv = document.createElement('div');
        contentDiv.className = 'outline-content';

        // Check if node has children
        if (data.children && data.children.length > 0) {
            // Add toggle arrow
            const toggle = document.createElement('span');
            toggle.className = 'outline-toggle';
            toggle.innerHTML = '›';
            if (isExpanded) {
                toggle.classList.add('expanded');
            }
            contentDiv.appendChild(toggle);

            // Add text
            const textSpan = document.createElement('span');
            textSpan.className = 'outline-text';
            textSpan.textContent = data.text;
            contentDiv.appendChild(textSpan);

            // Create children list
            const childrenUl = document.createElement('ul');
            childrenUl.className = 'outline-children';
            if (isExpanded) {
                childrenUl.classList.add('expanded');
            }

            // Add children
            data.children.forEach(child => {
                const shouldExpand = data.level < 1; // Expand first two levels
                childrenUl.appendChild(createOutlineNode(child, shouldExpand));
            });

            li.appendChild(contentDiv);
            li.appendChild(childrenUl);

            // Add click event to toggle
            contentDiv.addEventListener('click', function(e) {
                e.stopPropagation();
                const isExpanded = childrenUl.classList.contains('expanded');

                if (isExpanded) {
                    // Collapse
                    toggle.classList.remove('expanded');
                    childrenUl.classList.remove('expanded');
                    expandedNodes--;
                } else {
                    // Expand
                    toggle.classList.add('expanded');
                    childrenUl.classList.add('expanded');
                    expandedNodes++;
                }
                updateStats();
            });
        } else {
            // No children - add class for proper indentation
            li.classList.add('no-children');

            const textSpan = document.createElement('span');
            textSpan.className = 'outline-text';
            textSpan.textContent = data.text;
            contentDiv.appendChild(textSpan);

            li.appendChild(contentDiv);
        }

        return li;
    }

    function initializeMindMap() {
        const container = document.getElementById('mindMapContainer');
        container.innerHTML = '';
        totalNodes = 0;
        expandedNodes = 0;

        // Create controls
        const controlsDiv = document.createElement('div');
        controlsDiv.className = 'outline-controls';
        controlsDiv.innerHTML = `
                <button onclick="expandAll()">
                    Expand All
                </button>
                <button onclick="collapseAll()">
                    Collapse All
                </button>
                <button onclick="expandToLevel(2)">
                    Show 2 Levels
                </button>
                <button onclick="expandToLevel(3)">
                    Show 3 Levels
                </button>
                <div class="outline-stats">
                    <span id="nodeStats"></span>
                </div>
            `;
        container.appendChild(controlsDiv);

        // Create outline container
        const outlineContainer = document.createElement('div');
        outlineContainer.className = 'outline-container';

        // Create root list
        const rootUl = document.createElement('ul');
        rootUl.className = 'outline-list';
        rootUl.appendChild(createOutlineNode(mindMapData, true));

        outlineContainer.appendChild(rootUl);
        container.appendChild(outlineContainer);

        updateStats();
    }

    function updateStats() {
        const statsElement = document.getElementById('nodeStats');
        if (statsElement) {
            const allExpandable = document.querySelectorAll('.outline-toggle').length;
            const currentExpanded = document.querySelectorAll('.outline-toggle.expanded').length;
            statsElement.textContent = `${currentExpanded} / ${allExpandable} sections expanded`;
        }
    }

    function expandAll() {
        const allToggles = document.querySelectorAll('.outline-toggle');
        const allChildren = document.querySelectorAll('.outline-children');

        allToggles.forEach(toggle => {
            toggle.classList.add('expanded');
        });

        allChildren.forEach(children => {
            children.classList.add('expanded');
        });

        updateStats();
    }

    function collapseAll() {
        const allToggles = document.querySelectorAll('.outline-toggle');
        const allChildren = document.querySelectorAll('.outline-children');

        allToggles.forEach(toggle => {
            toggle.classList.remove('expanded');
        });

        allChildren.forEach(children => {
            children.classList.remove('expanded');
        });

        updateStats();
    }

    function expandToLevel(maxLevel) {
        // First collapse all
        collapseAll();

        // Then expand nodes up to specified level
        for (let level = 0; level < maxLevel; level++) {
            const levelItems = document.querySelectorAll(`.level-${level}`);
            levelItems.forEach(item => {
                const toggle = item.querySelector(':scope > .outline-content > .outline-toggle');
                const children = item.querySelector(':scope > .outline-children');

                if (toggle && children) {
                    toggle.classList.add('expanded');
                    children.classList.add('expanded');
                }
            });
        }

        updateStats();
    }

    // Quiz Functions
    function initializeQuiz() {
        const container = document.getElementById('quizContainer');
        container.innerHTML = '';

        quizQuestions.forEach((q, index) => {
            const questionDiv = document.createElement('div');
            questionDiv.className = 'quiz-question mb-4 sm:mb-6 p-3 sm:p-4 bg-gray-50 rounded';

            const questionText = document.createElement('h3');
            questionText.className = 'font-semibold mb-2 sm:mb-3 text-sm sm:text-base';
            questionText.textContent = `${index + 1}. ${q.question}`;
            questionDiv.appendChild(questionText);

            const optionsDiv = document.createElement('div');
            optionsDiv.className = 'space-y-2';

            q.options.forEach((option, optIndex) => {
                const label = document.createElement('label');
                label.className = 'flex items-start space-x-2 cursor-pointer hover:bg-gray-100 p-2 rounded';

                const input = document.createElement('input');
                input.type = 'radio';
                input.name = `question-${index}`;
                input.value = optIndex;
                input.className = 'text-blue-600 mt-0.5';

                const text = document.createElement('span');
                text.className = 'text-sm sm:text-base';
                text.textContent = option;

                label.appendChild(input);
                label.appendChild(text);
                optionsDiv.appendChild(label);
            });

            questionDiv.appendChild(optionsDiv);

            const feedbackDiv = document.createElement('div');
            feedbackDiv.className = 'quiz-feedback text-sm sm:text-base';
            feedbackDiv.id = `feedback-${index}`;
            questionDiv.appendChild(feedbackDiv);

            container.appendChild(questionDiv);
        });
    }

    function checkAnswers() {
        let score = 0;

        quizQuestions.forEach((q, index) => {
            const selected = document.querySelector(`input[name="question-${index}"]:checked`);
            const feedbackDiv = document.getElementById(`feedback-${index}`);

            if (selected) {
                const selectedValue = parseInt(selected.value);
                if (selectedValue === q.correct) {
                    score++;
                    feedbackDiv.className = 'quiz-feedback correct-answer text-sm sm:text-base';
                    feedbackDiv.textContent = '✓ Correct! ' + q.explanation;
                } else {
                    feedbackDiv.className = 'quiz-feedback incorrect-answer text-sm sm:text-base';
                    feedbackDiv.textContent = '✗ Incorrect. ' + q.explanation;
                }
                feedbackDiv.style.display = 'block';
            } else {
                feedbackDiv.className = 'quiz-feedback incorrect-answer text-sm sm:text-base';
                feedbackDiv.textContent = '⚠ Please select an answer.';
                feedbackDiv.style.display = 'block';
            }
        });

        const scoreDisplay = document.getElementById('scoreDisplay');
        scoreDisplay.textContent = `Score: ${score}/${quizQuestions.length} (${Math.round(score/quizQuestions.length * 100)}%)`;
        scoreDisplay.classList.remove('hidden');

        if (score === quizQuestions.length) {
            scoreDisplay.className = 'mt-4 text-lg sm:text-xl font-semibold text-green-600';
        } else if (score >= quizQuestions.length * 0.7) {
            scoreDisplay.className = 'mt-4 text-lg sm:text-xl font-semibold text-blue-600';
        } else {
            scoreDisplay.className = 'mt-4 text-lg sm:text-xl font-semibold text-orange-600';
        }
    }

    function resetQuiz() {
        const inputs = document.querySelectorAll('input[type="radio"]');
        inputs.forEach(input => input.checked = false);

        const feedbacks = document.querySelectorAll('.quiz-feedback');
        feedbacks.forEach(feedback => {
            feedback.style.display = 'none';
            feedback.textContent = '';
        });

        document.getElementById('scoreDisplay').classList.add('hidden');
    }
</script>
</body>
</html>
